|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.53 USD | -0.81% |
|
-0.42% | -1.75% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-08 | Morgan Stanley Adjusts Price Target BioNTech to $119 From $126, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIONTECH SE | Bio Therapeutic Drugs | -0.81% | -0.42% | -1.75% | -16.24% | -55.02% | 23.65B |  |  | |
- Stock Market
- Stocks
- BNTX Stock
- Charts BioNTech SE
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
